The company is a pioneer in the development and clinical application of ultrasound accelerated thrombolysis, which has resulted in the EKOS EkoSonic Endovascular System. This system is used by interventional radiologists, cardiologists, and vascular surgeons worldwide to provide faster, safer, and more complete dissolution of thrombus. The company's products include the EkoSonic endovascular system with MACH4e, which allows for the controlled and selective infusion of physician-specified fluids. EKOS Corporation's clinical application of microsonic technologies has revolutionized the treatment of vascular thrombosis, providing patients with a more effective and efficient treatment option.